Sam Altman and his husband have reportedly invested in a gene-editing startup which aims to eliminate hereditary diseases ...

KAIST announced on the 14th of November that it has been selected as a major participating institution in the 'Lunit ...

Astronaut Chen Dong, commander of the three-member Shenzhou-20 crew, is out of the Shenzhou-21 spaceship's return capsule ...

Nikhil Agarwal, Sushant Sachdeva, Andrew Ollett, Anjana Badrinarayanan, Sabyasachi Mukherjee, and Karthish Manthiram win the ...

The immune system faces a delicate balancing act: it must be aggressive enough to fight infections and cancer, yet restrained enough to ...

KHSC and Queen’s neurosurgeon-scientists develop a low-cost tool to collect MRI-linked tumor samples for aggressive form of brain cancer.

CRISPR Therapeutics AG is rated a Buy with $1.9B cash, prudent management, and undervalued shares. Learn more about CRSP ...

To maintain a perpetually “refreshed” look, cosmetic treatments are being sought earlier and more often. But what does it ...

Detailed price information for Cellectis S.A. ADR (CLLS-Q) from The Globe and Mail including charting and trades.

Researchers in Melbourne have engineered a new class of lipid nanoparticles with complex internal structures that can be ...